| Theme | The Current State of Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas | |
|---|---|---|
| Title | Use of ERCP for the Diagnosis of IPMN | |
| Publish Date | 2014/12 | |
| Author | Taro Hara | Department of Endoscopy, Chiba Cancer Center |
| Author | Dai Ikebe | Department of Clinical Pathology, Chiba Cancer Center |
| Author | Emiri Kita | Department of Gastroenterology, Chiba Cancer Center |
| Author | Akiko Tsujimoto | Department of Gastroenterology, Chiba Cancer Center |
| Author | Nami Nakamura | Department of Gastroenterology, Chiba Cancer Center |
| Author | Takuto Suzuki | Department of Endoscopy, Chiba Cancer Center |
| Author | Kentaro Sudo | Department of Gastroenterology, Chiba Cancer Center |
| Author | Kazuki Nakamura | Department of Gastroenterology, Chiba Cancer Center |
| Author | Taketo Yamaguchi | Department of Gastroenterology, Chiba Cancer Center |
| [ Summary ] | Pancreatic juice cytology using endoscopic retrograde cholangio-pancreatography (ERCP) not only offers information on pathological conformation but also aids in the classification of the IPMN subtype. Peroral pancreatovideoscopy (POPS) in the assessment of intraductal papillary mucinous neoplasm (IPMN) has an important role in the differential diagnosis of malignant and benign IPMNs, and in the determination of the resection line. Characteristic POPS findings of IPMN are divided into 4 categories that are closely correlated with malignancy and IPMN subtype. | |